Pharmacology and structure of P2Y receptors

I von Kügelgen, K Hoffmann - Neuropharmacology, 2016 - Elsevier
Abstract P2Y receptors are G-protein-coupled receptors (GPCRs) for extracellular
nucleotides. There are eight mammalian P2Y receptor subtypes (P2Y 1, P2Y 2, P2Y 4, P2Y …

NG 2‐glia and their functions in the central nervous system

L Dimou, V Gallo - Glia, 2015 - Wiley Online Library
In the central nervous system, NG2‐glia represent a neural cell population that is distinct
from neurons, astrocytes, and oligodendrocytes. While in the past the main role ascribed to …

Oligodendrocyte death initiates synchronous remyelination to restore cortical myelin patterns in mice

TW Chapman, GE Olveda, X Bame, E Pereira… - Nature …, 2023 - nature.com
Myelin degeneration occurs in neurodegenerative diseases and aging. In these conditions,
resident oligodendrocyte progenitor cells (OPCs) differentiate into oligodendrocytes that …

[HTML][HTML] Temporal oligodendrocyte lineage progression: in vitro models of proliferation, differentiation and myelination

A Barateiro, A Fernandes - Biochimica et Biophysica Acta (BBA)-Molecular …, 2014 - Elsevier
Oligodendrocytes are neuroglial cells responsible, within the central nervous system, for
myelin sheath formation that provides an electric insulation of axons and accelerate the …

Oligodendrocyte dysfunction in amyotrophic lateral sclerosis: mechanisms and therapeutic perspectives

S Raffaele, M Boccazzi, M Fumagalli - Cells, 2021 - mdpi.com
Myelin is the lipid-rich structure formed by oligodendrocytes (OLs) that wraps the axons in
multilayered sheaths, assuring protection, efficient saltatory signal conduction and metabolic …

Pathophysiological role of purines and pyrimidines in neurodevelopment: unveiling new pharmacological approaches to congenital brain diseases

M Fumagalli, D Lecca, MP Abbracchio… - Frontiers in …, 2017 - frontiersin.org
In recent years, a substantial body of evidence has emerged demonstrating that purine and
pyrimidine synthesis and metabolism play major roles in controlling embryonic and fetal …

Oligodendrocyte development and myelination in neurodevelopment: molecular mechanisms in health and disease

A Barateiro, D Brites… - Current pharmaceutical …, 2016 - ingentaconnect.com
Oligodendrocytes are the myelinating cells of the central nervous system that constitute
about 5 to 10% of the total glial population. These cells are responsible for myelin sheath …

G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination

HJ Yang, A Vainshtein, G Maik-Rachline… - Nature …, 2016 - nature.com
While the formation of myelin by oligodendrocytes is critical for the function of the central
nervous system, the molecular mechanism controlling oligodendrocyte differentiation …

Pharmacology of P2Y receptors

I von Kügelgen - Brain research bulletin, 2019 - Elsevier
Abstract P2Y receptors are G-protein-coupled receptors (GPCRs) for extracellular
nucleotides. There are eight mammalian P2Y receptor subtypes divided into two subgroups …

Ascl1/Mash1 promotes brain oligodendrogenesis during myelination and remyelination

H Nakatani, E Martin, H Hassani… - Journal of …, 2013 - Soc Neuroscience
Oligodendrocytes are the myelin-forming cells of the CNS. They differentiate from
oligodendrocyte precursor cells (OPCs) that are produced from progenitors throughout life …